Literature DB >> 10846071

Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo.

Z M Zheng1, J Quintero, E S Reid, C Gocke, C C Baker.   

Abstract

Alternative splicing is a critical component of the early to late switch in papillomavirus gene expression. In bovine papillomavirus type 1 (BPV-1), a switch in 3' splice site utilization from an early 3' splice site at nucleotide (nt) 3225 to a late-specific 3' splice site at nt 3605 is essential for expression of the major capsid (L1) mRNA. Three viral splicing elements have recently been identified between the two alternative 3' splice sites and have been shown to play an important role in this regulation. A bipartite element lies approximately 30 nt downstream of the nt 3225 3' splice site and consists of an exonic splicing enhancer (ESE), SE1, followed immediately by a pyrimidine-rich exonic splicing suppressor (ESS). A second ESE (SE2) is located approximately 125 nt downstream of the ESS. We have previously demonstrated that the ESS inhibits use of the suboptimal nt 3225 3' splice site in vitro through binding of cellular splicing factors. However, these in vitro studies did not address the role of the ESS in the regulation of alternative splicing. In the present study, we have analyzed the role of the ESS in the alternative splicing of a BPV-1 late pre-mRNA in vivo. Mutation or deletion of just the ESS did not significantly change the normal splicing pattern where the nt 3225 3' splice site is already used predominantly. However, a pre-mRNA containing mutations in SE2 is spliced predominantly using the nt 3605 3' splice site. In this context, mutation of the ESS restored preferential use of the nt 3225 3' splice site, indicating that the ESS also functions as a splicing suppressor in vivo. Moreover, optimization of the suboptimal nt 3225 3' splice site counteracted the in vivo function of the ESS and led to preferential selection of the nt 3225 3' splice site even in pre-mRNAs with SE2 mutations. In vitro splicing assays also showed that the ESS is unable to suppress splicing of a pre-mRNA with an optimized nt 3225 3' splice site. These data confirm that the function of the ESS requires a suboptimal upstream 3' splice site. A surprising finding of our study is the observation that SE1 can stimulate both the first and the second steps of splicing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846071      PMCID: PMC112086          DOI: 10.1128/jvi.74.13.5902-5910.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

Review 2.  Splicing of messenger RNA precursors.

Authors:  R A Padgett; P J Grabowski; M M Konarska; S Seiler; P A Sharp
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

Review 3.  Pre-mRNA splicing.

Authors:  M R Green
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

4.  Scanning from an independently specified branch point defines the 3' splice site of mammalian introns.

Authors:  C W Smith; E B Porro; J G Patton; B Nadal-Ginard
Journal:  Nature       Date:  1989-11-16       Impact factor: 49.962

5.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  A compensatory base change in human U2 snRNA can suppress a branch site mutation.

Authors:  Y Zhuang; A M Weiner
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

7.  Parameters that affect in vitro splicing of bovine papillomavirus type 1 late pre-mRNAs.

Authors:  Z M Zheng; C C Baker
Journal:  J Virol Methods       Date:  2000-03       Impact factor: 2.014

8.  Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing.

Authors:  J Wu; J L Manley
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

9.  Recognition of the TACTAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA.

Authors:  R Parker; P G Siliciano; C Guthrie
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

10.  The role of the polypyrimidine stretch at the SV40 early pre-mRNA 3' splice site in alternative splicing.

Authors:  X Y Fu; H Ge; J L Manley
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  16 in total

1.  Distribution and characterization of regulatory elements in the human genome.

Authors:  Jacek Majewski; Jurg Ott
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

Review 2.  Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.

Authors:  Zhi-Ming Zheng
Journal:  J Biomed Sci       Date:  2004 May-Jun       Impact factor: 8.410

Review 3.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

4.  Differing patterns of selection in alternative and constitutive splice sites.

Authors:  Kavita Garg; Phil Green
Journal:  Genome Res       Date:  2007-06-07       Impact factor: 9.043

5.  Functionally antagonistic sequences are required for normal autoregulation of Drosophila tra-2 pre-mRNA splicing.

Authors:  D S Chandler; M E McGuffin; W Mattox
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

6.  Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.

Authors:  Z M Zheng; E S Reid; C C Baker
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.

Authors:  Sohrab Bodaghi; Rong Jia; Zhi-Ming Zheng
Journal:  Virology       Date:  2009-02-01       Impact factor: 3.616

8.  Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.

Authors:  Xiaomin Zhao; Margaret Rush; Stefan Schwartz
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.

Authors:  Xuefeng Liu; Akila Mayeda; Mingfang Tao; Zhi-Ming Zheng
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.

Authors:  Masahiko Ajiro; Shuang Tang; John Doorbar; Zhi-Ming Zheng
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.